IP Library Granted Patent US 8,936,777
Granted Patent B2
US 8,936,777 · App. 13/577,674 · Granted Jan 20, 2015

Methods and apparatus for synthesizing imaging agents, and intermediates thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,936,777
App. No.
13/577,674
Granted
Jan 20, 2015
Kind
B2
Abstract

The present invention generally relates to methods and system for the synthesis of imaging agents, and precursors thereof. The methods may exhibit improved yields and may allow for the large-scale synthesis of imaging agents, including imaging agents comprising a radioisotope (e.g., 18 F). Various embodiments of the invention may be useful as sensors, diagnostic tools, and the like. In some cases, methods for evaluating perfusion, including myocardial perfusion, are provided. Synthetic methods of the invention have also been incorporated into an automated synthesis unit to prepare and purify imaging agents that comprise a radioisotope. In some embodiments, the present invention provides a novel methods and systems comprising imaging agent 1, including methods of imaging in a subject comprising administering a composition comprising imaging agent 1 to a subject by injection, infusion, or any other known method, and imaging the area of the subject wherein the event of interest is located.

Claims (112)

1. A method of synthesizing an imaging agent comprising the formula:

wherein:

W is alkyl or heteroalkyl, optionally substituted;

R 1 is alkyl, optionally substituted;

R 2 is hydrogen or halide;

each R 3 can be the same or different and is alkyl optionally substituted with an imaging moiety or heteroalkyl optionally substituted with an imaging moiety; and

n is 1, 2, 3, 4, or 5;

the method comprising steps of:

reacting precursor compounds comprising the formulae:

wherein:

n is 1, 2, 3, 4, or 5;

R 1 is alkyl, optionally substituted;

R 2 is hydrogen or halide;

R 3 can be the same or different and are alkyl, heteroalkyl, or a carbonyl-containing group, each optionally substituted;

R 5 is hydroxyl or halide; and

R 6 is alkyl, heteroalkyl, or a carbonyl-containing group, each optionally substituted;

wherein, when R 5 is hydroxyl, at least one of R 6 and R 3 comprises a leaving group;

or wherein R 5 is halide, at least one of R 6 or R 3 comprises a hydroxyl, to produce a compound comprising the formula:

wherein:

W is alkyl or heteroalkyl, optionally substituted;

R 1 is alkyl, optionally substituted;

R 2 is hydrogen or halide;

each R 3 can be the same or different and is alkyl optionally substituted with hydroxyl or heteroalkyl optionally substituted with hydroxyl; wherein at least one R 3 comprises hydroxyl; and

n is 1, 2, 3, 4, or 5;

reacting a compound comprising the formula:

wherein:

W is alkyl or heteroalkyl, optionally substituted;

R 1 is alkyl, optionally substituted;

R 2 is hydrogen or halide;

each R 3 can be the same or different and is alkyl optionally substituted with hydroxyl or heteroalkyl optionally substituted with hydroxyl; wherein at least one R 3 comprises hydroxyl; and

n is 1, 2, 3, 4, or 5;

with a sulfonate-containing species to produce a sulfonate-containing compound comprising the formula:

wherein:

W is alkyl or heteroalkyl, optionally substituted;

R 1 is alkyl, optionally substituted;

R 2 is hydrogen or halide;

each R 3 can be the same or different and is alkyl optionally substituted with a sulfonate-containing group or heteroalkyl optionally substituted with a sulfonate-containing group; wherein at least one R 3 comprises a sulfonate-containing group; and

n is 1, 2, 3, 4, or 5;

replacing the sulfonate-containing group of the sulfonate-containing compound with an imaging moiety in the presence of a bicarbonate salt to yield an imaging agent comprising the formula:

wherein:

W is alkyl or heteroalkyl, optionally substituted;

R 1 is alkyl, optionally substituted;

R 2 is hydrogen or halide;

each R 3 can be the same or different and is alkyl optionally substituted with an imaging moiety or heteroalkyl optionally substituted with an imaging moiety; and

n is 1, 2, 3, 4, or 5; provided that at least one imaging moiety is present in the imaging agent.

2. A method of synthesizing a product comprising an 18 F-species, comprising reacting a compound comprising the formula:

wherein:

R 1 is alkyl;

R 2 is hydrogen or halogen; and

R 3 is alkyl substituted with a sulfonate-containing group, alkoxy substituted with a sulfonate-containing group, or alkoxyalkyl substituted with a sulfonate-containing group; with an 18 F-containing species in the presence of a bicarbonate salt to form the product comprising the 18 F-species.

3. The method of claim 2 , wherein the sulfonate-containing group is mesylate, tosylate, triflate, or 1,2-cyclic sulfate.

4. The method of claim 2 , wherein R 1 is a methyl, ethyl, propyl, i-propyl, n-butyl, i-butyl, s-butyl, or t-butyl.

5. The method of claim 2 , wherein the product comprises the formula:

6. A method of synthesizing an imaging agent precursor comprising:

reacting a compound comprising formula (III):

wherein:

W is alkyl or heteroalkyl, optionally substituted;

R 1 is alkyl, optionally substituted;

R 2 is hydrogen or halide;

each R 3 can be the same or different and is alkyl optionally substituted with a leaving group or heteroalkyl optionally substituted with a leaving group; and

n is 1, 2, 3, 4, or 5;

provided at least one R 3 is substituted with a leaving group;

with a nucleophile, wherein the nucleophile replaces the leaving group to produce the imaging agent precursor.

7. A method of claim 6 , wherein reacting the compound with the nucleophile occurs in the presence of a base.

8. A method of claim 7 , wherein the base is a metal or metal salt.

9. A method of claim 6 , wherein reacting the compound with the nucleophile occurs in the presence of a catalyst.

10. A method of claim 9 , wherein the catalyst is a tetraalkylammonium iodide.

11. A method of claim 6 , wherein:

W is —O(CH 2 )—;

R 1 is t-butyl;

R 2 is chloride; and

R 3 is alkyl substituted with a leaving group.

12. A method of synthesizing an imaging agent, comprising:

contacting an imaging agent precursor with a fluoride species and a bicarbonate salt under conditions that result in the fluoride species replacing the leaving group to produce an imaging agent comprising the fluoride species,

wherein the molar ratio of bicarbonate salt to imaging agent precursor is less than about 1.5:1.

13. A method of manufacturing an imaging agent comprising the formula:

wherein the method comprises,

(a) contacting a tosylate precursor comprising the structure:

with a fluoride species associated with an ammonium salt in the presence of a bicarbonate salt;

(b) heating the mixture of (a);

(c) cooling the heated mixture;

(d) adding H 2 O to the cooled mixture;

(e) purifying the mixture from the hydrated mixture of (d) using HPLC with an H 2 O/MeCN eluent; and

(f) diluting the eluent with a solution of ascorbic acid or a salt thereof.

14. A method of synthesizing a fluorinated compound comprising 18 F, comprising:

reacting, in the presence of a bicarbonate salt, (i) a precursor of the fluorinated compound comprising an alkoxyalkyl group substituted with a halide or a sulfonate-containing group, with (ii) a salt comprising a fluoride species and weakly coordinating cation, wherein the fluoride species is enriched in 18 F.

15. A method of synthesizing a product comprising an 18 F-species, comprising reacting a compound comprising the formula:

wherein R is -(lower alkyl)-sulfonate, R 1 is an C 1 -C 10 alkyl, and R 2 is H or a halogen;

with an 18 F-containing species in the presence of a tetraalkylammonium bicarbonate salt to form the product comprising the 18 F-species.

16. A method comprising:

reacting a compound comprising formula (V):

wherein:

W is alkyl or heteroalkyl, optionally substituted;

R 1 is alkyl, optionally substituted; and

R 2 is hydrogen or halide,

with a nucleophile or a radical species to produce a compound comprising formula (VI):

17. A method comprising:

reacting precursor compounds comprising formulae:

via an etherification reaction to form a first compound comprising the formula:

exposing the first compound to a reducing agent to form a second compound comprising a benzylic alcohol;

treating the second compound with phosphorus tribromide to form a third compound comprising a benzylic bromide;

reacting the third compound with ethylene glycol to produce a fourth compound comprising the formula:

reacting the fourth compound with a sulfonate-containing species to form a product comprising a sulfonate-containing precursor of an imaging agent.

18. A compound comprising formula:

19. A method of imaging a subject, comprising:

subjecting a subject to stress;

administering to the subject a dose of an imaging agent comprising the formula:

in an amount less than about 20 mCi; and

acquiring at least one first image of a portion of the subject.

20. A cassette for the preparation of an imaging agent comprising the formula:

comprising: (i) a vessel containing an imaging agent precursor comprising the formula:

and (ii) a conduit for adding a source of 18 F.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jun 27, 2019
From: JPMORGAN CHASE BANK, N.A.
To: LANTHEUS MEDICAL IMAGING, INC.
Reel/Frame 049623/0123 →
NOTICE OF SUCCESSION OF AGENCY Recorded May 25, 2017
From: CREDIT SUISSE AG
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 042586/0699 →
RELEASE OF SECURITY INTEREST IN CERTAIN PATENTS Recorded May 25, 2017
From: JPMORGAN CHASE BANK, N.A.
To: LANTHEUS MEDICAL IMAGING, INC.
Reel/Frame 042586/0710 →
RELEASE OF SECURITY INTEREST IN CERTAIN PATENTS Recorded Mar 30, 2017
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: LANTHEUS HOLDINGS, INC.; LANTHEUS MEDICAL IMAGING, INC.; LANTHEUS MI REAL ESTATE, LLC
Reel/Frame 042115/0715 →
SECURITY AGREEMENT Recorded Jun 30, 2015
From: LANTHEUS MEDICAL IMAGING, INC.
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS COLLATERAL AGENT
Reel/Frame 036013/0516 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 3, 2013
From: CESATI, RICHARD R.; CHEESMAN, EDWARD H.; LAZEWATSKY, JOEL; RADEKE, HEIKE S.; CASTNER, JAMES F.; MONGEAU, ENRICO; ZDANKIEWICZ, DIANNE D.; SIEGLER, ROBERT WILBURN; DEVINE, MARYBETH
To: LANTHEUS MEDICAL IMAGING, INC.
Reel/Frame 030739/0506 →
AMENDMENT NUMBER ONE TO GRANT OF A SECURITY INTEREST - PATENTS Recorded Jul 3, 2013
From: LANTHEUS MI INTERMEDIATE, INC.; LANTHEUS MEDICAL IMAGING, INC.; LANTHEUS MI REAL ESTATE, LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 030747/0814 →